EPISODE · Sep 13, 2024 · 24 MIN
Future MDMA Treatment Following FDA's Rejection
from Cato Podcast
The FDA's rejection of MDMA as a treatment may well be a short-term setback for legally helping people with PTSD and other disorders. Mason Marks of Harvard Law School’s Petrie-Flom Center for Health Law Policy offers his assessment. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
The FDA's rejection of MDMA as a treatment may well be a short-term setback for legally helping people with PTSD and other disorders. Mason Marks of Harvard Law School’s Petrie-Flom Center for Health Law Policy offers his assessment. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Future MDMA Treatment Following FDA's Rejection
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m